The interplay of the PKD3 with SREBP1 and lipogenesis pathways in regulating lipid metabolism may have important implications in prostate cancer development and potentially provide novel molecular targets for prevention and treatment of the cancer. This evidence concerns the gene PRKD3 and prostate carcinoma.